March 5, 2019

Dr. Rita Numerof spoke with BioPharma Dive about drug manufacturers launching authorized generics of their own branded drugs, and the strategy behind making this unconventional move.

Holding onto customers via a lower list price is preferable, even if authorized generics essentially “cannibalize your own products before your competition does.”

Read the full story at